Stem Point Capital LP Portfolio Holdings

Stem Point Capital LP

  • $401 Billion
  • Q4 2024

Stem Point Capital LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $401 Billion distributed in 58 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Syndax Pharmaceuticals Inc with a value of $38B, Roivant Sciences Ltd. with a value of $32.1B, Immunovant, Inc. with a value of $27.7B, Merus N.V. with a value of $25.9B, and Crinetics Pharmaceuticals, Inc. with a value of $16.2B.

Examining the 13F form we can see an increase of $66.6B in the current position value, from $334B to 401B.

Stem Point Capital LP is based out at New York, NY

Below you can find more details about Stem Point Capital LP portfolio as well as his latest detailed transactions.

Portfolio value $401 Billion
Healthcare: $340 Billion
ETFs: $928 Million
Consumer Defensive: $75 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$862M
$38 Billion 9.48% of portfolio
2,872,601
Q4 2024 Added 65.93%
$7.39B
$32.1 Billion 8.01% of portfolio
2,712,778
Q4 2024 Reduced 2.06%
$3.55B
$27.7 Billion 6.92% of portfolio
1,118,508
Q4 2024 Added 66.69%
$2.04B
$25.9 Billion 6.45% of portfolio
614,812
Q4 2024 Added 45.96%
$1.75B
$16.2 Billion 4.05% of portfolio
317,060
Q4 2024 Added 48.29%
$2.34B
$14.7 Billion 3.68% of portfolio
375,845
Q4 2024 New
$16.5B
$13.4 Billion 3.34% of portfolio
193,623
Q4 2024 Added 49.53%
$5.72B
$12 Billion 2.99% of portfolio
416,968
Q4 2024 Added 752.38%
$2.58B
$11.9 Billion 2.97% of portfolio
584,328
Q4 2024 Added 107.17%
$2.84B
$11.6 Billion 2.91% of portfolio
208,016
Q4 2024 Added 404.06%
$3.26B
$11.4 Billion 2.84% of portfolio
145,234
Q4 2024 New
$1.49B
$10.8 Billion 2.68% of portfolio
641,964
Q4 2024 Added 667.33%
Praxis Precision Medicines I
-
$10.3 Billion 2.58% of portfolio
-
Q4 2024 Reduced 22.9%
$122B
$9.39 Billion 2.34% of portfolio
166,068
Q4 2024 Reduced 39.68%
$899M
$8.92 Billion 2.23% of portfolio
721,209
Q4 2024 Added 140.4%
$3.63B
$8.47 Billion 2.11% of portfolio
193,535
Q4 2024 Added 1,062.09%
$1.36B
$7.81 Billion 1.95% of portfolio
145,876
Q4 2024 Added 195.21%
$10.5B
$7.36 Billion 1.84% of portfolio
106,610
Q4 2024 New
$1.88B
$7.19 Billion 1.79% of portfolio
166,307
Q4 2024 New
$843M
$7.03 Billion 1.75% of portfolio
949,401
Q4 2024 New
$27.7B
$7 Billion 1.75% of portfolio
61,403
Q4 2024 New
$734M
$6.98 Billion 1.74% of portfolio
500,966
Q4 2024 Reduced 71.83%
Biohaven LTD
-
$6.96 Billion 1.74% of portfolio
-
Q4 2024 Reduced 13.87%
Vistagen Therapeutics Inc
-
$5.95 Billion 1.48% of portfolio
-
Q4 2024 Added 26.08%
$1.72B
$5.47 Billion 1.37% of portfolio
141,714
Q4 2024 New
Acelyrin Inc
-
$5.35 Billion 1.34% of portfolio
-
Q4 2024 Added 29.36%
Surrozen Inc
-
$5.03 Billion 1.26% of portfolio
-
Q4 2024 Added 91.66%
Mineralys Therapeutics Inc
-
$4.93 Billion 1.23% of portfolio
-
Q4 2024 New
Neumora Therapeutics Inc.
-
$4.54 Billion 1.13% of portfolio
-
Q4 2024 New
$203M
$4.32 Billion 1.08% of portfolio
579,500
Q4 2024 New
$2.91B
$4.28 Billion 1.07% of portfolio
101,809
Q4 2024 New
$456M
$4.27 Billion 1.07% of portfolio
545,800
Q4 2024 New
$4.39B
$3.93 Billion 0.98% of portfolio
83,576
Q4 2024 Added 477.82%
Contineum Therapeutics Inc
-
$3.89 Billion 0.97% of portfolio
-
Q4 2024 New
$1.58B
$3.54 Billion 0.88% of portfolio
132,706
Q4 2024 Added 566.86%
$708M
$3.41 Billion 0.85% of portfolio
270,983
Q4 2024 New
Jasper Therapeutics Inc
-
$2.89 Billion 0.72% of portfolio
-
Q4 2024 New
Tourmaline Bio Inc
-
$2.56 Billion 0.64% of portfolio
-
Q4 2024 Added 127.65%
Enliven Therapeutics Inc
-
$2.18 Billion 0.54% of portfolio
-
Q4 2024 New
Helix Acquisition Corp Ii
-
$2.11 Billion 0.53% of portfolio
-
Q4 2024 Added 0.45%
$38.1M
$1.76 Billion 0.44% of portfolio
332,394
Q4 2024 Reduced 64.75%
$514M
$1.59 Billion 0.4% of portfolio
90,000
Q4 2024 New
Perceptive Cap Solutions Cor
-
$1.53 Billion 0.38% of portfolio
-
Q2 2024 New
$3.8B
$1.31 Billion 0.33% of portfolio
28,136
Q4 2024 New
Cidara Therapeutics Inc
-
$1.28 Billion 0.32% of portfolio
-
Q4 2024 New
$53.2M
$726 Million 0.18% of portfolio
200,475
Q4 2024 New
Tectonic Therapeutic Inc
-
$436 Million 0.11% of portfolio
-
Q4 2024 New

Summary

  • Portfolio
  • No. of Stocks 58
  • Current Value $401 Billion
  • Prior Value $334 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 22 stocks
  • Additional Purchases 19 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Stem Point Capital LP Portfolio

Follow Stem Point Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stem Point Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Stem Point Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email